NCT03467867 2026-04-06
A Study of Venetoclax and Rituximab/Hyaluronidase Human in Relapsed/Refractory CLL
Georgetown University
Phase 2 Active not recruiting
Georgetown University
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
Dana-Farber Cancer Institute
National Institutes of Health Clinical Center (CC)